The trial marks a significant milestone for Inceptor Bio's efforts to address the unmet medical needs of patients with clear cell Renal Cell Carcinoma (ccRCC) IB-T101 is an autologous CD70 CAR-T ...
来自MSN1 个月
Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial ...Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer among adults.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈